Nonselective Beta-Blockers Do Not Affect Survival in Cirrhotic Patients with Ascites-Reference-Cited by-同舟云学术

Nonselective Beta-Blockers Do Not Affect Survival in Cirrhotic Patients with Ascites

Published:2018-05-03 Issue:7 Volume:63 Page:1737-1746
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Facciorusso Antonio^ORCID,Roy Sunil,Livadas Sarantis,Fevrier-Paul Adwalia,Wekesa Clara,Kilic Ismail Dogu,Chaurasia Amit Kumar,Sadeq Mina,Muscatiello Nicola

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/article/10.1007/s10620-018-5092-6/fulltext.html

Reference37 articles.

1. de Franchis R, Abraldes JG, Bajaj J, et al. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752.

2. Merli M, Lucidi C, Di Gregorio V, et al. The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis. Liver Int. 2015;35:362–369.

3. Reiberger T, Ferlitsch A, Payer BA, et al. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol. 2013;58:911–921.

4. Mookerjee RP, Pavesi M, Thomsen KL, et al. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. J Hepatol. 2016;64:574–582.

5. Sersté T, Francoz C, Durand F, et al. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study. J Hepatol. 2011;55:794–799.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Selective Beta-Blockers in Patients with Cirrhosis: Current Evidence and Controversy;Liver Cirrhosis and Its Complications - Advances in Diagnosis and Management;2024-06-17

2. The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension;2024-03-29

3. Association of non-selective β blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis;Annals of Medicine;2024-01-25

4. NON-SELECTIVE BETA-BLOCKERS IN CIRRHOTIC PATIENTS WITH REFRACTORY ASCITES: WHERE ARE WE?;Arquivos de Gastroenterologia;2024

5. Advances in the management of complications from cirrhosis;Gastroenterology Report;2023-12-22